SlideShare una empresa de Scribd logo
1 de 56
What WikiCite can learn from
biomedical citation networks
Jodi Schneider
WikiCite, 2017-05-22
jschneider@pobox.com
http://jodischneider.com/jodi.html
@jschneider
My hats
• Librarian
now: Professor of future librarians and info managers
• Ontologist
• Journal editor/founder (not quite a publisher!)
co-founder of open access Code4Lib Journal c. 2007
• Researcher
scholarly communication, Biomedical informatics, Linked Data,
argumentation, Computer-Supported Collaboration, Wikipedia
• Wikipedian
mainly EN.WP, EN.WikiQuote
• User
acawiki.org (Community Manager c. 2009)
bibliographic management software
articles, books, etc. in many, many fields
Acawiki.org
Which evidence do we take into
account for a given purpose?
Hierarchy of Evidence
Figure credit: SUNY Downstate Medical Center. Medical Research
Library of Brooklyn. Evidence Based Medicine Course. A Guide to
Research Methods: The Evidence Pyramid:
http://library.downstate.edu/EBM2/2100.htm
BUT: we cannot judge
evidence in isolation.
Approaches include:
• Appraisal
Approaches include:
• Appraisal
• Aggregation
Figure credit: Forest plot from Underhill, Kristen, Paul
Montgomery, and Don Operario. "Sexual abstinence only
programmes to prevent HIV infection in high income countries:
systematic review." BMJ 335.7613 (2007): 248.
Figure credit: Duke University Medical Center Library. Introduction to
Evidence-based Practice. What is Evidence-Based Practice (EBP)?
http://guides.mclibrary.duke.edu/c.php?g=158201&p=1036021
• Appraisal
• Aggregation
• Contextualization
Approaches include:
How trustworthy and valid is a
given scientific “fact”?
How fragile is this knowledge?
What supports it? What holds it up?
By Biochem1 (Own work) CC BY-SA 3.0 via Wikimedia
Commons
https://commons.wikimedia.org/wiki/File:‫.جنگا_ست_یک‬JPG
Can it be shored up?
By Biochem1 (Own work) CC BY-SA 3.0 via Wikimedia Commons
https://commons.wikimedia.org/wiki/Category:Jenga#/media/File:
‫.جنگا‬JPG
Do citations show the lineage of
an idea?
{{Existing “facts”}} + {{New “facts”}}
{{Existing “facts”}} + {{New “facts”}}
{{Stuff you cite}}
Examples from discussion
sections of reports of
Randomized Controlled Trials
“This” work agrees with…
• “This is in accordance with earlier studies
in the ambulatory surgical setting [3]” -
PMC1637100
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Definitions and background info
• “Self-efficacy, which may relate to
motivation, is the perceived confidence in
one's ability to accomplish a specific task
[19].” - PMC2194735
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Presenting a range of evidence
• “Except in one study [20], short-term
administration of GH transiently worsened
insulin resistance [19,53] and increased
fasting glucose levels [53].” - PMC1865086
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Clause-level changes in meaning
• “Two of four randomised clinical trials
…have found a difference in admission
rate [12,19] and two have not [22,23].” -
PMC1142326
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
A single citation can support a
whole paragraph
• Dutton and colleagues [8] described a series
of 81 coagulopathic trauma patients treated
with rFVIIa. Of these, 20 received rFVIIa for
treatment of coagulopathy related to TBI. Six
of these patients had additional polytrauma.
The outcome of these patients was poor and
15 of 20 patients died. The authors attributed
this high mortality rate to the severity of brain
injury. None of the 81 trauma patients in this
series had any clinical indication of TE
events.”
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Discussing treatments, outcomes,
other authors’ conclusions
• Dutton and colleagues [8] described a series
of 81 coagulopathic trauma patients treated
with rFVIIa. Of these, 20 received rFVIIa for
treatment of coagulopathy related to TBI. Six
of these patients had additional polytrauma.
The outcome of these patients was poor and
15 of 20 patients died. The authors
attributed this high mortality rate to the
severity of brain injury. None of the 81 trauma
patients in this series had any clinical
indication of TE events.”
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Sometimes several parallel
paragraphs.
• Dutton and colleagues [8] described a
series of 81 …patients treated with rFVIIa”
• “Zaaroor and Bar-Lavie [23] reported the
first series of five patients …”
• “Morenski and colleagues [24] described
…three pediatric … cases”
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Multiple citations in a paragraph
• “Berger et al. [42] compared the efficacy of
hypertonic saline and mannitol to reduce ICP after
a combination of two different neuronal injuries.
Initially, ….The authors demonstrated that …After
…. It is remarkable that … An accumulation
…These different effects … [42]. Furthermore,
Prough et al. observed a higher regional cerebral
blood flow in dogs with induced intracerebral
hemorrhage after hypertonic saline without any
increase of the CPP [43].” - PMC1297608
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
Avoiding a 1-sentence paragraph?
• “Berger et al. [42] compared the efficacy of
hypertonic saline and mannitol to reduce ICP after
a combination of two different neuronal injuries.
Initially, ….The authors demonstrated that …After
…. It is remarkable that … An accumulation
…These different effects … [42]. Furthermore,
Prough et al. observed a higher regional cerebral
blood flow in dogs with induced intracerebral
hemorrhage after hypertonic saline without any
increase of the CPP [43].” - PMC1297608
Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu.
Rhetorical moves and audience considerations in the discussion sections
of Randomized Controlled Trials of health interventions. To be presented
at European Conference on Argumentation, June 2017
“[Y]ou can transform a fact into
fiction or a fiction into fact just by
adding or subtracting references”
- Bruno Latour
... two miRNAs, miRNA-372 and-373, function as potential novel oncogenes in
testicular germ cell tumors by inhibition of LATS2 expression, which suggests that
Lats2 is an important tumor suppressor (Voorhoeve et al., 2006).
Raver-Shapira et.al, JMolCell 2007
miR-372 and miR-373 target the Lats2 tumor suppressor (Voorhoeve et al., 2006)
Yabuta, JBioChem 2007:
As claims get cited, they become facts:
To investigate the possibility that miR-372 and miR-373 suppress the
expression of LATS2, we...
Therefore, these results point to LATS2 as a mediator of the miR-372 and miR-373
effects on cell proliferation and tumorigenicity,
Voorhoeve et al, Cell, 2006:
Hypothesis
Implication
Cited Implication
Fact
Slide credit: Anita DeWaard: 'Stories that persuade with data' - talk at CENDI meeting January 9 2014
https://www.slideshare.net/anitawaard/stories-that-persuade-with-data-talk-at-cendi-meeting-january-
9-2014/6
“The conversion of hypothesis to
fact through citation alone.”
- Stephen Greenberg
Greenberg, Steven A.
"Understanding belief using
citation networks." Journal of
evaluation in clinical
practice 17.2 (2011): 389-393.
http://dx.doi.org/
10.1111/j.1365-
2753.2011.01646.x
“The conversion of hypothesis to fact
through citation alone.”
- Stephen Greenberg
Greenberg, Steven A. "How citation distortions create unfounded
authority: analysis of a citation network." BMJ 339 (2009): b2680.
https://doi.org/10.1136/bmj.b2680
Funded grants with citation bias &
citation distortion.
Greenberg, Steven A. "How citation distortions create unfounded
authority: analysis of a citation network." BMJ 339 (2009): b2680.
https://doi.org/10.1136/bmj.b2680
Modeling arguments and
evidence
SEPIO – evidence lines
Brush, Matthew, Kent Shefchek, and Melissa Haendel. "SEPIO: a
semantic model for the integration and analysis of scientific
evidence." International Conference on Biomedical Ontology and
BioCreative. 2016. http://ceur-ws.org/Vol-1747/IT605_ICBO2016.pdf
“A proposition has_evidence
one or more evidence lines, which have_supporting_data
one or more data items used in evaluation of the
proposition’s truth.”
SEPIO – evidence lines example
Brush, Matthew, Kent Shefchek, and Melissa Haendel. "SEPIO: a
semantic model for the integration and analysis of scientific
evidence." International Conference on Biomedical Ontology and
BioCreative. 2016. http://ceur-ws.org/Vol-1747/IT605_ICBO2016.pdf
“A simplified account of existing evidence related to this proposition is presented below,
presenting summaries of five evidence lines (E1-E5) from five studies relevant to the
classification of the variant for Fabry Disease:
E1. Six affected individuals with the variant were found to have reduced GLA enzyme
activity.
E2. The variant was absent from 528 unaffected controls.
E3. The variant is predicted to cause abnormal splicing that inserts additional sequence.
E4. Pedigree analyses showed Fabry Disease phenotypes segregating with the variant.
E5. Population databases show high frequency of individuals homozygous for the variant.”
SEPIO – evidence lines example
Brush, Matthew, Kent Shefchek, and Melissa Haendel. "SEPIO: a
semantic model for the integration and analysis of scientific
evidence." International Conference on Biomedical Ontology and
BioCreative. 2016. http://ceur-ws.org/Vol-1747/IT605_ICBO2016.pdf
“A simplified account of existing evidence related to this proposition is presented below,
presenting summaries of five evidence lines (E1-E5) from five studies relevant to the
classification of the variant for Fabry Disease:
E1. Six affected individuals with the variant were found to have reduced GLA enzyme
activity.
E2. The variant was absent from 528 unaffected controls.
E3. The variant is predicted to cause abnormal splicing that inserts additional sequence.
E4. Pedigree analyses showed Fabry Disease phenotypes segregating with the variant.
E5. Population databases show high frequency of individuals homozygous for the variant.”
Modeling arguments and
evidence
SEE
Bö̈ lling, Christian, Michael Weidlich, and Hermann-Georg Holzhütter.
"SEE: structured representation of scientific evidence in the biomedical
domain using Semantic Web techniques." Journal of Biomedical
Semantics 5.1 (2014): 1.
SEE
Bö̈ lling, Christian, Michael Weidlich, and Hermann-Georg Holzhütter.
"SEE: structured representation of scientific evidence in the biomedical
domain using Semantic Web techniques." Journal of Biomedical
Semantics 5.1 (2014): 1.
Modeling arguments and
evidence
Micropublications
Clark, Tim, Paolo N. Ciccarese, and Carole A. Goble.
"Micropublications: a semantic model for claims, evidence, arguments
and annotations in biomedical communications." Journal of Biomedical
Semantics 5.28 (2014). http://dx.doi.org/10.1186/2041-1480-5-28
Jodi Schneider, Paolo Ciccarese, Tim Clark, Richard D. Boyce. “Using the Micropublications ontology and the
Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base.” Linked
Science at ISWC 2014 http://ceur-ws.org/Vol-1282/lisc2014_submission_8.pdf
Formalizing knowledge
Cataloging evidence types for
knowledge bases.
Boyce, R.D.: A Draft Evidence Taxonomy and Inclusion Criteria for the
Drug Interaction Knowledge Base (DIKB),
http://purl.net/net/drug-interaction-knowledge-base/evidence-types-and-
inclusion-criteria
Biological Expression Language
Rastegar-Mojarad, Majid, Ravikumar Komandur Elayavilli, and
Hongfang Liu. "BELTracker: evidence sentence retrieval for BEL
statements." Database 2016 (2016).
See also: http://openbel.org
Corpora of Interest
Voorhoeve et al. (116) employed a novel
strategy by combining an miRNA vector library
and corresponding bar code array…
miR-372 and miR-373 were consequently found
to permit proliferation and tumorigenesis of
these primary cells carrying both oncogenic RAS
and wild-type p53,
probably through direct inhibition of the
expression of the tumor-suppressor LATS2 and
subsequent neutralization of the p53 pathway.
to identify miRNAs that when overexpressed
could substitute for p53 loss and allow continued
proliferation in the context of Ras activation
TAC Corpus:
Curated Collection of 500 Citing > 50 Cited Papers
Voorhoeve et al. (2006), A Genetic
Screen …
In mammals, a near-perfect complementarity between
miRNAs and protein coding genes almost never exists, making
it difficult to directly pinpoint relevant downstream targets of
a miRNA. Several algorithms were developed that predict
miRNA targets, most notably TargetScanS, PicTar, and
miRanda (John et al., 2004, Lewis et al., 2005 and Robins et al.,
2005).
These programs predict dozens to hundreds of target genes
per miRNA, making it difficult to directly infer the cellular
pathways affected by a given miRNA. Furthermore, the
biological effect of the downregulation depends greatly on the
cellular context, which exemplifies the need to deduce miRNA
functions by in vivo genetic screens in well-defined model
systems.
The cancerous process can be modeled by in vitro neoplastic
transformation assays in primary human cells (Hahn et al.,
1999). Using this system, sets of genetic elements required for
transformation were identified. For example, the joint
expression of the telomerase reverse transcriptase subunit
(hTERT),
oncogenic H-RASV12, and SV40-small t antigen combined with
the suppression of p53 and p16INK4A were sufficient to
render primary human fibroblasts tumorigenic (Voorhoeve
and Agami, 2003).
Goal
Method
Result
Con
clusion
Citing PapersReference Paper
Slide credit: Anita DeWaard:
Argumentation in biology papers
https://www.slideshare.net/anitawaard/argumentation-in-biology-papers/27
Take away messages
• Biomedicine has evolved multiple
approaches for managing and appraising
individual papers and bodies of “facts”.
• Citations come in many shapes and sizes.
• Citations may support “facts” – as part of a
larger scientific fabric that includes data,
evidence, arguments.
• Powermove: identify the critical supports
(think Jenga)
Take away messages
• Network analysis may help identify
problematic citation practices.
• Modeling arguments can help identify the
robustness of a claimed “fact”.
• Semantic models could enable inference-
based reasoning and citation network
querying.
• Relevant citation corpora exist.
Slide credit: Anita DeWaard: Epistemics, https://www.slideshare.net/anitawaard/epistemics/6
Anita’s insight:
Detect and Track Metadiscourse
• Voorhoeve et al., 2006: “These miRNAs neutralize p53- mediated CDK
inhibition, possibly through direct inhibition of the expression of the tumor
suppressor LATS2.”
• Kloosterman and Plasterk, 2006: “In a genetic screen, miR-372 and miR-373
were found to allow proliferation of primary human cells that express
oncogenic RAS and active p53, possibly by inhibiting the tumor suppressor
LATS2 (Voorhoeve et al., 2006).”
• Yabuta et al., 2007: “[On the other hand,] two miRNAs, miRNA-372 and-373,
function as potential novel oncogenes in testicular germ cell tumors by
inhibition of LATS2 expression, which suggests that Lats2 is an important
tumor suppressor (Voorhoeve et al., 2006).”
• Okada et al., 2011: “Two oncogenic miRNAs, miR-372 and miR-373, directly
inhibit the expression of Lats2, thereby allowing tumorigenic growth in the
presence of p53 (Voorhoeve et al., 2006).”
Slide credit: Based on Anita DeWaard: How to persuade with data
https://www.slideshare.net/anitawaard/stories-thatpersuadev-4/18
Metadiscourse: some progress
• Hedging cues, speculative language, modality/negation:
• Light et al [6]: finding speculative language
• Wilbur et al (Hagit) [7]: focus, polarity, certainty, evidence, and
directionality
• Thompson et al (Sophia) [8]: level of speculation, type/source
of the evidence and level of certainty
• Sentiment detection (e.g. Kim and Hovy [9] a.m.o.):
• Holder of the opinion, strength, polarity as ‘mathematical
function’ acting on main propositional content
• Can make this part of the semantic web: (e.g., Ontology for
Reasoning, Certainty and Attribution, ORCA [10]):
• Value (Presumed True, Probable, Possible, Unknown)
• Source (Author, Named Other, Unknown)
• Basis (Data, Reasoning, Unknown) Slide credit: Anita DeWaard:
How to persuade with data
https://www.slideshare.net/anita
waard/stories-thatpersuadev-
4/19
Anita’s citations
[6] Light M, Qiu XY, Srinivasan P. (2004). The language of bioscience: facts,
speculations, and statements in between. BioLINK 2004: Linking Biological
Literature, Ontologies and Databases 2004:17-24.
[7] Wilbur WJ, Rzhetsky A, Shatkay H (2006). New directions in biomedical
text annotations: definitions, guidelines and corpus construction. BMC
Bioinformatics 2006, 7:356.
[8] Thompson P., Venturi G., McNaught J, Montemagni S, Ananiadou S.
(2008). Categorising modality in biomedical texts. Proc. LREC 2008 Wkshp
Building and Evaluating Resources for Biomedical Text Mining 2008.
[9] Kim, S-M. Hovy, E.H. (2004). Determining the Sentiment of Opinions.
Proceedings of the COLING conference, Geneva, 2004.
[10] de Waard, A. and Schneider, J. (2012) An Ontology of Reasoning,
Certainty and Attribution (ORCA), ISWC 2012, http://ceur-ws.org/Vol-
930/p2.pdf

Más contenido relacionado

La actualidad más candente

Preventing Suicide in Discharged Service Members
Preventing Suicide in Discharged Service MembersPreventing Suicide in Discharged Service Members
Preventing Suicide in Discharged Service Members
Kyri Barilone
 
srep15786.pdf GWAS corr AyurVeda Prakriti
srep15786.pdf GWAS corr AyurVeda Prakritisrep15786.pdf GWAS corr AyurVeda Prakriti
srep15786.pdf GWAS corr AyurVeda Prakriti
Shalendra Roepan
 
Contribution of genome-wide association studies to scientific research: a pra...
Contribution of genome-wide association studies to scientific research: a pra...Contribution of genome-wide association studies to scientific research: a pra...
Contribution of genome-wide association studies to scientific research: a pra...
Mutiple Sclerosis
 
A common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organsA common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organs
Kevin Jaglinski
 
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Rodrigo Vargas Zapana
 
Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...
Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...
Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...
Emily Strack
 
St. Jude Insider-2014-03-26
St. Jude Insider-2014-03-26St. Jude Insider-2014-03-26
St. Jude Insider-2014-03-26
RAJASHREE RANA
 

La actualidad más candente (20)

Journal of Alzheimer's Disease, 2015
Journal of Alzheimer's Disease, 2015Journal of Alzheimer's Disease, 2015
Journal of Alzheimer's Disease, 2015
 
Biostats2019 5
Biostats2019 5Biostats2019 5
Biostats2019 5
 
CV_Roland_Matsouaka
CV_Roland_MatsouakaCV_Roland_Matsouaka
CV_Roland_Matsouaka
 
BiTeM / SIBTex @ TREC CDS 2014
BiTeM / SIBTex @ TREC CDS 2014BiTeM / SIBTex @ TREC CDS 2014
BiTeM / SIBTex @ TREC CDS 2014
 
Preventing Suicide in Discharged Service Members
Preventing Suicide in Discharged Service MembersPreventing Suicide in Discharged Service Members
Preventing Suicide in Discharged Service Members
 
Human Subjects Global Issues
Human Subjects Global IssuesHuman Subjects Global Issues
Human Subjects Global Issues
 
srep15786.pdf GWAS corr AyurVeda Prakriti
srep15786.pdf GWAS corr AyurVeda Prakritisrep15786.pdf GWAS corr AyurVeda Prakriti
srep15786.pdf GWAS corr AyurVeda Prakriti
 
CMT update winter 2014
CMT update winter 2014CMT update winter 2014
CMT update winter 2014
 
B03510609
B03510609B03510609
B03510609
 
Debunking Made Easy, AHCJ 2014
Debunking Made Easy, AHCJ 2014Debunking Made Easy, AHCJ 2014
Debunking Made Easy, AHCJ 2014
 
Contribution of genome-wide association studies to scientific research: a pra...
Contribution of genome-wide association studies to scientific research: a pra...Contribution of genome-wide association studies to scientific research: a pra...
Contribution of genome-wide association studies to scientific research: a pra...
 
A common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organsA common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organs
 
Amia tb-review-15
Amia tb-review-15Amia tb-review-15
Amia tb-review-15
 
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
Benefits os Statins in Elderly Subjects Without Established Cardiovascular Di...
 
Managing incidental findings in genomic investigations: ethical issues - Carl...
Managing incidental findings in genomic investigations: ethical issues - Carl...Managing incidental findings in genomic investigations: ethical issues - Carl...
Managing incidental findings in genomic investigations: ethical issues - Carl...
 
Deep learning-approach
Deep learning-approachDeep learning-approach
Deep learning-approach
 
Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...
Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...
Physical Activity and White Matter Hyperintensities, A Systematic Review of Q...
 
Glymour aaai
Glymour aaaiGlymour aaai
Glymour aaai
 
St. Jude Insider-2014-03-26
St. Jude Insider-2014-03-26St. Jude Insider-2014-03-26
St. Jude Insider-2014-03-26
 
2016 march bms eau symposium full presentation v24_030916
2016 march bms eau symposium full presentation v24_0309162016 march bms eau symposium full presentation v24_030916
2016 march bms eau symposium full presentation v24_030916
 

Similar a What WikiCite can learn from biomedical citation networks--Wikicite2017--2017-05-22

NSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_Medicine
NSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_MedicineNSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_Medicine
NSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_Medicine
Ribitzky
 
DUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docx
DUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docxDUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docx
DUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docx
sagarlesley
 

Similar a What WikiCite can learn from biomedical citation networks--Wikicite2017--2017-05-22 (20)

EBM ON SYSTEMATIC REVIEW 2021.pptx
EBM ON SYSTEMATIC REVIEW 2021.pptxEBM ON SYSTEMATIC REVIEW 2021.pptx
EBM ON SYSTEMATIC REVIEW 2021.pptx
 
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
 
Big Data Analytics in the Health Domain
Big Data Analytics in the Health DomainBig Data Analytics in the Health Domain
Big Data Analytics in the Health Domain
 
Ahmed Negida, MBBCh - Biography
Ahmed Negida, MBBCh - BiographyAhmed Negida, MBBCh - Biography
Ahmed Negida, MBBCh - Biography
 
Cmt newsletter-winter-2015
Cmt newsletter-winter-2015Cmt newsletter-winter-2015
Cmt newsletter-winter-2015
 
NSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_Medicine
NSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_MedicineNSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_Medicine
NSF_Post-Workshop_Book_White_Space_RD_Knowledge_Mining_Personalized_Medicine
 
Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015 Aysun Karatas MedicReS World Congress 2015
Aysun Karatas MedicReS World Congress 2015
 
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
 
RDD Conf Day 2: Josh Lounsberry (Canadian Neuromuscular Disease Network)
RDD Conf Day 2: Josh Lounsberry (Canadian Neuromuscular Disease Network)RDD Conf Day 2: Josh Lounsberry (Canadian Neuromuscular Disease Network)
RDD Conf Day 2: Josh Lounsberry (Canadian Neuromuscular Disease Network)
 
Evidence Based Medicine by Dr. Harmanjit Singh, GMC, Patiala
Evidence Based Medicine by Dr. Harmanjit Singh, GMC, PatialaEvidence Based Medicine by Dr. Harmanjit Singh, GMC, Patiala
Evidence Based Medicine by Dr. Harmanjit Singh, GMC, Patiala
 
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial HypertensionTrial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
 
Casemix, management, and mortality of patients receiving emergency neurosurge...
Casemix, management, and mortality of patients receiving emergency neurosurge...Casemix, management, and mortality of patients receiving emergency neurosurge...
Casemix, management, and mortality of patients receiving emergency neurosurge...
 
Research methodology
 Research methodology Research methodology
Research methodology
 
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
 
27 shweta journal club presentation
27 shweta journal club presentation27 shweta journal club presentation
27 shweta journal club presentation
 
dual antiplatelet in stroke meta analysis
dual antiplatelet in stroke meta analysisdual antiplatelet in stroke meta analysis
dual antiplatelet in stroke meta analysis
 
DUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docx
DUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docxDUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docx
DUE 1162017 10 P.M ESTTHIS IS A 4 PART HIV SPSS PROJECT. ATTAC.docx
 
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...
 
MedicalResearch.com: Medical Research Exclusive Interviews November 5 2014
MedicalResearch.com:  Medical Research Exclusive Interviews November 5  2014MedicalResearch.com:  Medical Research Exclusive Interviews November 5  2014
MedicalResearch.com: Medical Research Exclusive Interviews November 5 2014
 
27 shweta lamsal journal-club-presentation
27 shweta lamsal journal-club-presentation27 shweta lamsal journal-club-presentation
27 shweta lamsal journal-club-presentation
 

Más de jodischneider

Continued citation of bad science and what we can do about it--2021-04-20
Continued citation of bad science and what we can do about it--2021-04-20Continued citation of bad science and what we can do about it--2021-04-20
Continued citation of bad science and what we can do about it--2021-04-20
jodischneider
 
Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...
Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...
Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...
jodischneider
 
Problematic citations--Workshop-on-Open-Citations--2018-09-03
Problematic citations--Workshop-on-Open-Citations--2018-09-03Problematic citations--Workshop-on-Open-Citations--2018-09-03
Problematic citations--Workshop-on-Open-Citations--2018-09-03
jodischneider
 
Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...
Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...
Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...
jodischneider
 

Más de jodischneider (20)

Continued citation of bad science and what we can do about it--2021-04-20
Continued citation of bad science and what we can do about it--2021-04-20Continued citation of bad science and what we can do about it--2021-04-20
Continued citation of bad science and what we can do about it--2021-04-20
 
Continued citation of bad science and what we can do about it--2021-02-19
Continued citation of bad science and what we can do about it--2021-02-19Continued citation of bad science and what we can do about it--2021-02-19
Continued citation of bad science and what we can do about it--2021-02-19
 
The problems of post retraction citation - and mitigation strategies that wor...
The problems of post retraction citation - and mitigation strategies that wor...The problems of post retraction citation - and mitigation strategies that wor...
The problems of post retraction citation - and mitigation strategies that wor...
 
Towards knowledge maintenance in scientific digital libraries with the keysto...
Towards knowledge maintenance in scientific digital libraries with the keysto...Towards knowledge maintenance in scientific digital libraries with the keysto...
Towards knowledge maintenance in scientific digital libraries with the keysto...
 
Methods Pyramids as an Organizing Structure for Evidence-Based Medicine--SIGC...
Methods Pyramids as an Organizing Structure for Evidence-Based Medicine--SIGC...Methods Pyramids as an Organizing Structure for Evidence-Based Medicine--SIGC...
Methods Pyramids as an Organizing Structure for Evidence-Based Medicine--SIGC...
 
Annotation examples--Fribourg--2019-09-03
Annotation examples--Fribourg--2019-09-03Annotation examples--Fribourg--2019-09-03
Annotation examples--Fribourg--2019-09-03
 
Argumentation mining--an introduction for linguists--Fribourg--2019-09-02
Argumentation mining--an introduction for linguists--Fribourg--2019-09-02Argumentation mining--an introduction for linguists--Fribourg--2019-09-02
Argumentation mining--an introduction for linguists--Fribourg--2019-09-02
 
Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...
Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...
Beyond Randomized Clinical Trials: emerging innovations in reasoning about he...
 
Problematic citations--Workshop-on-Open-Citations--2018-09-03
Problematic citations--Workshop-on-Open-Citations--2018-09-03Problematic citations--Workshop-on-Open-Citations--2018-09-03
Problematic citations--Workshop-on-Open-Citations--2018-09-03
 
Modeling Alzheimer’s Disease research claims, evidence, and arguments from a ...
Modeling Alzheimer’s Disease research claims, evidence, and arguments from a ...Modeling Alzheimer’s Disease research claims, evidence, and arguments from a ...
Modeling Alzheimer’s Disease research claims, evidence, and arguments from a ...
 
Innovations in reasoning about health: the case of the Randomized Clinical Tr...
Innovations in reasoning about health: the case of the Randomized Clinical Tr...Innovations in reasoning about health: the case of the Randomized Clinical Tr...
Innovations in reasoning about health: the case of the Randomized Clinical Tr...
 
Viewing universities as landscapes of scholarship, VIVO keynote, 2017-08-04
Viewing universities as landscapes of scholarship, VIVO keynote, 2017-08-04Viewing universities as landscapes of scholarship, VIVO keynote, 2017-08-04
Viewing universities as landscapes of scholarship, VIVO keynote, 2017-08-04
 
Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...
Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...
Medication safety as a use case for argumentation mining, Dagstuhl seminar 16...
 
Acquiring and representing drug-drug interaction knowledge and evidence, TRIA...
Acquiring and representing drug-drug interaction knowledge and evidence, TRIA...Acquiring and representing drug-drug interaction knowledge and evidence, TRIA...
Acquiring and representing drug-drug interaction knowledge and evidence, TRIA...
 
Persons, documents, models: organising and structuring information for the We...
Persons, documents, models: organising and structuring information for the We...Persons, documents, models: organising and structuring information for the We...
Persons, documents, models: organising and structuring information for the We...
 
Synthesizing knowledge from disagreement -- Manchester -- 2015-05-06
Synthesizing knowledge from disagreement -- Manchester -- 2015-05-06Synthesizing knowledge from disagreement -- Manchester -- 2015-05-06
Synthesizing knowledge from disagreement -- Manchester -- 2015-05-06
 
Synthesizing knowledge from disagreement -cwi-2015-04-23
Synthesizing knowledge from disagreement -cwi-2015-04-23Synthesizing knowledge from disagreement -cwi-2015-04-23
Synthesizing knowledge from disagreement -cwi-2015-04-23
 
Packaging ideas--nanopublications-in-the-humanities--Europeana--2015-04-21
Packaging ideas--nanopublications-in-the-humanities--Europeana--2015-04-21Packaging ideas--nanopublications-in-the-humanities--Europeana--2015-04-21
Packaging ideas--nanopublications-in-the-humanities--Europeana--2015-04-21
 
How communities curate knowledge & how ontologists can help -Eurecom--2015-01-19
How communities curate knowledge & how ontologists can help -Eurecom--2015-01-19How communities curate knowledge & how ontologists can help -Eurecom--2015-01-19
How communities curate knowledge & how ontologists can help -Eurecom--2015-01-19
 
ERCIM Marie Curie - Alain Bensoussan Fellowship info - ERCIM 25 years Pisa
ERCIM Marie Curie - Alain Bensoussan Fellowship info - ERCIM 25 years PisaERCIM Marie Curie - Alain Bensoussan Fellowship info - ERCIM 25 years Pisa
ERCIM Marie Curie - Alain Bensoussan Fellowship info - ERCIM 25 years Pisa
 

Último

Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
panagenda
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 

Último (20)

FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
Cyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdfCyberprint. Dark Pink Apt Group [EN].pdf
Cyberprint. Dark Pink Apt Group [EN].pdf
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 

What WikiCite can learn from biomedical citation networks--Wikicite2017--2017-05-22

  • 1. What WikiCite can learn from biomedical citation networks Jodi Schneider WikiCite, 2017-05-22 jschneider@pobox.com http://jodischneider.com/jodi.html @jschneider
  • 2. My hats • Librarian now: Professor of future librarians and info managers • Ontologist • Journal editor/founder (not quite a publisher!) co-founder of open access Code4Lib Journal c. 2007 • Researcher scholarly communication, Biomedical informatics, Linked Data, argumentation, Computer-Supported Collaboration, Wikipedia • Wikipedian mainly EN.WP, EN.WikiQuote • User acawiki.org (Community Manager c. 2009) bibliographic management software articles, books, etc. in many, many fields
  • 4. Which evidence do we take into account for a given purpose?
  • 5. Hierarchy of Evidence Figure credit: SUNY Downstate Medical Center. Medical Research Library of Brooklyn. Evidence Based Medicine Course. A Guide to Research Methods: The Evidence Pyramid: http://library.downstate.edu/EBM2/2100.htm
  • 6. BUT: we cannot judge evidence in isolation.
  • 8. Approaches include: • Appraisal • Aggregation Figure credit: Forest plot from Underhill, Kristen, Paul Montgomery, and Don Operario. "Sexual abstinence only programmes to prevent HIV infection in high income countries: systematic review." BMJ 335.7613 (2007): 248.
  • 9. Figure credit: Duke University Medical Center Library. Introduction to Evidence-based Practice. What is Evidence-Based Practice (EBP)? http://guides.mclibrary.duke.edu/c.php?g=158201&p=1036021 • Appraisal • Aggregation • Contextualization Approaches include:
  • 10. How trustworthy and valid is a given scientific “fact”?
  • 11. How fragile is this knowledge?
  • 12. What supports it? What holds it up? By Biochem1 (Own work) CC BY-SA 3.0 via Wikimedia Commons https://commons.wikimedia.org/wiki/File:‫.جنگا_ست_یک‬JPG
  • 13. Can it be shored up? By Biochem1 (Own work) CC BY-SA 3.0 via Wikimedia Commons https://commons.wikimedia.org/wiki/Category:Jenga#/media/File: ‫.جنگا‬JPG
  • 14. Do citations show the lineage of an idea?
  • 15. {{Existing “facts”}} + {{New “facts”}}
  • 16. {{Existing “facts”}} + {{New “facts”}} {{Stuff you cite}}
  • 17. Examples from discussion sections of reports of Randomized Controlled Trials
  • 18. “This” work agrees with… • “This is in accordance with earlier studies in the ambulatory surgical setting [3]” - PMC1637100 Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 19. Definitions and background info • “Self-efficacy, which may relate to motivation, is the perceived confidence in one's ability to accomplish a specific task [19].” - PMC2194735 Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 20. Presenting a range of evidence • “Except in one study [20], short-term administration of GH transiently worsened insulin resistance [19,53] and increased fasting glucose levels [53].” - PMC1865086 Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 21. Clause-level changes in meaning • “Two of four randomised clinical trials …have found a difference in admission rate [12,19] and two have not [22,23].” - PMC1142326 Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 22. A single citation can support a whole paragraph • Dutton and colleagues [8] described a series of 81 coagulopathic trauma patients treated with rFVIIa. Of these, 20 received rFVIIa for treatment of coagulopathy related to TBI. Six of these patients had additional polytrauma. The outcome of these patients was poor and 15 of 20 patients died. The authors attributed this high mortality rate to the severity of brain injury. None of the 81 trauma patients in this series had any clinical indication of TE events.” Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 23. Discussing treatments, outcomes, other authors’ conclusions • Dutton and colleagues [8] described a series of 81 coagulopathic trauma patients treated with rFVIIa. Of these, 20 received rFVIIa for treatment of coagulopathy related to TBI. Six of these patients had additional polytrauma. The outcome of these patients was poor and 15 of 20 patients died. The authors attributed this high mortality rate to the severity of brain injury. None of the 81 trauma patients in this series had any clinical indication of TE events.” Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 24. Sometimes several parallel paragraphs. • Dutton and colleagues [8] described a series of 81 …patients treated with rFVIIa” • “Zaaroor and Bar-Lavie [23] reported the first series of five patients …” • “Morenski and colleagues [24] described …three pediatric … cases” Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 25. Multiple citations in a paragraph • “Berger et al. [42] compared the efficacy of hypertonic saline and mannitol to reduce ICP after a combination of two different neuronal injuries. Initially, ….The authors demonstrated that …After …. It is remarkable that … An accumulation …These different effects … [42]. Furthermore, Prough et al. observed a higher regional cerebral blood flow in dogs with induced intracerebral hemorrhage after hypertonic saline without any increase of the CPP [43].” - PMC1297608 Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 26. Avoiding a 1-sentence paragraph? • “Berger et al. [42] compared the efficacy of hypertonic saline and mannitol to reduce ICP after a combination of two different neuronal injuries. Initially, ….The authors demonstrated that …After …. It is remarkable that … An accumulation …These different effects … [42]. Furthermore, Prough et al. observed a higher regional cerebral blood flow in dogs with induced intracerebral hemorrhage after hypertonic saline without any increase of the CPP [43].” - PMC1297608 Jodi Schneider, Graciela Rosemblat, Shabnam Tafreshi and Halil Kilicoglu. Rhetorical moves and audience considerations in the discussion sections of Randomized Controlled Trials of health interventions. To be presented at European Conference on Argumentation, June 2017
  • 27. “[Y]ou can transform a fact into fiction or a fiction into fact just by adding or subtracting references” - Bruno Latour
  • 28. ... two miRNAs, miRNA-372 and-373, function as potential novel oncogenes in testicular germ cell tumors by inhibition of LATS2 expression, which suggests that Lats2 is an important tumor suppressor (Voorhoeve et al., 2006). Raver-Shapira et.al, JMolCell 2007 miR-372 and miR-373 target the Lats2 tumor suppressor (Voorhoeve et al., 2006) Yabuta, JBioChem 2007: As claims get cited, they become facts: To investigate the possibility that miR-372 and miR-373 suppress the expression of LATS2, we... Therefore, these results point to LATS2 as a mediator of the miR-372 and miR-373 effects on cell proliferation and tumorigenicity, Voorhoeve et al, Cell, 2006: Hypothesis Implication Cited Implication Fact Slide credit: Anita DeWaard: 'Stories that persuade with data' - talk at CENDI meeting January 9 2014 https://www.slideshare.net/anitawaard/stories-that-persuade-with-data-talk-at-cendi-meeting-january- 9-2014/6
  • 29. “The conversion of hypothesis to fact through citation alone.” - Stephen Greenberg
  • 30. Greenberg, Steven A. "Understanding belief using citation networks." Journal of evaluation in clinical practice 17.2 (2011): 389-393. http://dx.doi.org/ 10.1111/j.1365- 2753.2011.01646.x
  • 31. “The conversion of hypothesis to fact through citation alone.” - Stephen Greenberg Greenberg, Steven A. "How citation distortions create unfounded authority: analysis of a citation network." BMJ 339 (2009): b2680. https://doi.org/10.1136/bmj.b2680
  • 32. Funded grants with citation bias & citation distortion. Greenberg, Steven A. "How citation distortions create unfounded authority: analysis of a citation network." BMJ 339 (2009): b2680. https://doi.org/10.1136/bmj.b2680
  • 34. SEPIO – evidence lines Brush, Matthew, Kent Shefchek, and Melissa Haendel. "SEPIO: a semantic model for the integration and analysis of scientific evidence." International Conference on Biomedical Ontology and BioCreative. 2016. http://ceur-ws.org/Vol-1747/IT605_ICBO2016.pdf “A proposition has_evidence one or more evidence lines, which have_supporting_data one or more data items used in evaluation of the proposition’s truth.”
  • 35. SEPIO – evidence lines example Brush, Matthew, Kent Shefchek, and Melissa Haendel. "SEPIO: a semantic model for the integration and analysis of scientific evidence." International Conference on Biomedical Ontology and BioCreative. 2016. http://ceur-ws.org/Vol-1747/IT605_ICBO2016.pdf “A simplified account of existing evidence related to this proposition is presented below, presenting summaries of five evidence lines (E1-E5) from five studies relevant to the classification of the variant for Fabry Disease: E1. Six affected individuals with the variant were found to have reduced GLA enzyme activity. E2. The variant was absent from 528 unaffected controls. E3. The variant is predicted to cause abnormal splicing that inserts additional sequence. E4. Pedigree analyses showed Fabry Disease phenotypes segregating with the variant. E5. Population databases show high frequency of individuals homozygous for the variant.”
  • 36. SEPIO – evidence lines example Brush, Matthew, Kent Shefchek, and Melissa Haendel. "SEPIO: a semantic model for the integration and analysis of scientific evidence." International Conference on Biomedical Ontology and BioCreative. 2016. http://ceur-ws.org/Vol-1747/IT605_ICBO2016.pdf “A simplified account of existing evidence related to this proposition is presented below, presenting summaries of five evidence lines (E1-E5) from five studies relevant to the classification of the variant for Fabry Disease: E1. Six affected individuals with the variant were found to have reduced GLA enzyme activity. E2. The variant was absent from 528 unaffected controls. E3. The variant is predicted to cause abnormal splicing that inserts additional sequence. E4. Pedigree analyses showed Fabry Disease phenotypes segregating with the variant. E5. Population databases show high frequency of individuals homozygous for the variant.”
  • 38. SEE Bö̈ lling, Christian, Michael Weidlich, and Hermann-Georg Holzhütter. "SEE: structured representation of scientific evidence in the biomedical domain using Semantic Web techniques." Journal of Biomedical Semantics 5.1 (2014): 1.
  • 39. SEE Bö̈ lling, Christian, Michael Weidlich, and Hermann-Georg Holzhütter. "SEE: structured representation of scientific evidence in the biomedical domain using Semantic Web techniques." Journal of Biomedical Semantics 5.1 (2014): 1.
  • 41. Micropublications Clark, Tim, Paolo N. Ciccarese, and Carole A. Goble. "Micropublications: a semantic model for claims, evidence, arguments and annotations in biomedical communications." Journal of Biomedical Semantics 5.28 (2014). http://dx.doi.org/10.1186/2041-1480-5-28
  • 42. Jodi Schneider, Paolo Ciccarese, Tim Clark, Richard D. Boyce. “Using the Micropublications ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base.” Linked Science at ISWC 2014 http://ceur-ws.org/Vol-1282/lisc2014_submission_8.pdf
  • 44. Cataloging evidence types for knowledge bases. Boyce, R.D.: A Draft Evidence Taxonomy and Inclusion Criteria for the Drug Interaction Knowledge Base (DIKB), http://purl.net/net/drug-interaction-knowledge-base/evidence-types-and- inclusion-criteria
  • 45. Biological Expression Language Rastegar-Mojarad, Majid, Ravikumar Komandur Elayavilli, and Hongfang Liu. "BELTracker: evidence sentence retrieval for BEL statements." Database 2016 (2016). See also: http://openbel.org
  • 47. Voorhoeve et al. (116) employed a novel strategy by combining an miRNA vector library and corresponding bar code array… miR-372 and miR-373 were consequently found to permit proliferation and tumorigenesis of these primary cells carrying both oncogenic RAS and wild-type p53, probably through direct inhibition of the expression of the tumor-suppressor LATS2 and subsequent neutralization of the p53 pathway. to identify miRNAs that when overexpressed could substitute for p53 loss and allow continued proliferation in the context of Ras activation TAC Corpus: Curated Collection of 500 Citing > 50 Cited Papers Voorhoeve et al. (2006), A Genetic Screen … In mammals, a near-perfect complementarity between miRNAs and protein coding genes almost never exists, making it difficult to directly pinpoint relevant downstream targets of a miRNA. Several algorithms were developed that predict miRNA targets, most notably TargetScanS, PicTar, and miRanda (John et al., 2004, Lewis et al., 2005 and Robins et al., 2005). These programs predict dozens to hundreds of target genes per miRNA, making it difficult to directly infer the cellular pathways affected by a given miRNA. Furthermore, the biological effect of the downregulation depends greatly on the cellular context, which exemplifies the need to deduce miRNA functions by in vivo genetic screens in well-defined model systems. The cancerous process can be modeled by in vitro neoplastic transformation assays in primary human cells (Hahn et al., 1999). Using this system, sets of genetic elements required for transformation were identified. For example, the joint expression of the telomerase reverse transcriptase subunit (hTERT), oncogenic H-RASV12, and SV40-small t antigen combined with the suppression of p53 and p16INK4A were sufficient to render primary human fibroblasts tumorigenic (Voorhoeve and Agami, 2003). Goal Method Result Con clusion Citing PapersReference Paper Slide credit: Anita DeWaard: Argumentation in biology papers https://www.slideshare.net/anitawaard/argumentation-in-biology-papers/27
  • 48. Take away messages • Biomedicine has evolved multiple approaches for managing and appraising individual papers and bodies of “facts”. • Citations come in many shapes and sizes. • Citations may support “facts” – as part of a larger scientific fabric that includes data, evidence, arguments. • Powermove: identify the critical supports (think Jenga)
  • 49. Take away messages • Network analysis may help identify problematic citation practices. • Modeling arguments can help identify the robustness of a claimed “fact”. • Semantic models could enable inference- based reasoning and citation network querying. • Relevant citation corpora exist.
  • 50.
  • 51.
  • 52.
  • 53. Slide credit: Anita DeWaard: Epistemics, https://www.slideshare.net/anitawaard/epistemics/6
  • 54. Anita’s insight: Detect and Track Metadiscourse • Voorhoeve et al., 2006: “These miRNAs neutralize p53- mediated CDK inhibition, possibly through direct inhibition of the expression of the tumor suppressor LATS2.” • Kloosterman and Plasterk, 2006: “In a genetic screen, miR-372 and miR-373 were found to allow proliferation of primary human cells that express oncogenic RAS and active p53, possibly by inhibiting the tumor suppressor LATS2 (Voorhoeve et al., 2006).” • Yabuta et al., 2007: “[On the other hand,] two miRNAs, miRNA-372 and-373, function as potential novel oncogenes in testicular germ cell tumors by inhibition of LATS2 expression, which suggests that Lats2 is an important tumor suppressor (Voorhoeve et al., 2006).” • Okada et al., 2011: “Two oncogenic miRNAs, miR-372 and miR-373, directly inhibit the expression of Lats2, thereby allowing tumorigenic growth in the presence of p53 (Voorhoeve et al., 2006).” Slide credit: Based on Anita DeWaard: How to persuade with data https://www.slideshare.net/anitawaard/stories-thatpersuadev-4/18
  • 55. Metadiscourse: some progress • Hedging cues, speculative language, modality/negation: • Light et al [6]: finding speculative language • Wilbur et al (Hagit) [7]: focus, polarity, certainty, evidence, and directionality • Thompson et al (Sophia) [8]: level of speculation, type/source of the evidence and level of certainty • Sentiment detection (e.g. Kim and Hovy [9] a.m.o.): • Holder of the opinion, strength, polarity as ‘mathematical function’ acting on main propositional content • Can make this part of the semantic web: (e.g., Ontology for Reasoning, Certainty and Attribution, ORCA [10]): • Value (Presumed True, Probable, Possible, Unknown) • Source (Author, Named Other, Unknown) • Basis (Data, Reasoning, Unknown) Slide credit: Anita DeWaard: How to persuade with data https://www.slideshare.net/anita waard/stories-thatpersuadev- 4/19
  • 56. Anita’s citations [6] Light M, Qiu XY, Srinivasan P. (2004). The language of bioscience: facts, speculations, and statements in between. BioLINK 2004: Linking Biological Literature, Ontologies and Databases 2004:17-24. [7] Wilbur WJ, Rzhetsky A, Shatkay H (2006). New directions in biomedical text annotations: definitions, guidelines and corpus construction. BMC Bioinformatics 2006, 7:356. [8] Thompson P., Venturi G., McNaught J, Montemagni S, Ananiadou S. (2008). Categorising modality in biomedical texts. Proc. LREC 2008 Wkshp Building and Evaluating Resources for Biomedical Text Mining 2008. [9] Kim, S-M. Hovy, E.H. (2004). Determining the Sentiment of Opinions. Proceedings of the COLING conference, Geneva, 2004. [10] de Waard, A. and Schneider, J. (2012) An Ontology of Reasoning, Certainty and Attribution (ORCA), ISWC 2012, http://ceur-ws.org/Vol- 930/p2.pdf

Notas del editor

  1. Is Wikipedia a gateway to biomedical research? (Lauren Maggio)
  2. Which evidence do we take into account for a given purpose? How trustworthy and valid is a given scientific “fact”? What supports it? What line of research established it? How many pieces can we remove before it tumbles?
  3. Greenberg, Steven A. "How citation distortions create unfounded authority: analysis of a citation network." BMJ 339 (2009): b2680. https://doi.org/10.1136/bmj.b2680 Latour, Bruno. Science in action: How to follow scientists and engineers through society. Harvard University Press, 1987. p33
  4. Greenberg, Steven A. "How citation distortions create unfounded authority: analysis of a citation network." BMJ 339 (2009): b2680. https://doi.org/10.1136/bmj.b2680 Latour, Bruno. Science in action: How to follow scientists and engineers through society. Harvard University Press, 1987. p33
  5. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  6. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  7. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  8. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  9. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  10. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  11. “A model of the evidence for and against the assertion escitalopram does not inhibit CYP2D6. This is based on the Micropublications ontology, and reuses the ev- idence taxonomy (dikbEvidence), terms (dikb), and data from the DIKB. The Drug Ontology (DRON) and Protein Ontology (PRO) are reused in semantic qualifiers. A more detailed view of Method Me1 is shown in Figure 1. "
  12. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  13. “The Biological Expression Language (BEL) is a language for representing scientific findings in the life sciences in a computable form. BEL is designed to represent scientific findings by capturing causal and correlative relationships in context, where context can include information about the biological and experimental system in which the relationships were observed, the supporting publications cited and the curation process used.” http://openbel.org
  14. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  15. “As is commonly the case, different evidence is used by each lab - either because certain data were not accessible, or some labs judged certain data to be unreliable or irrelevant to the claim, or some labs interpreted the same data in different ways. SEPIO translates this scenario into the following narrative and set of instances to be represented in its formal modeling of the data.”
  16. https://www.slideshare.net/anitawaard/stories-thatpersuadev-4/19